ENTRADA THERAPEUTICS INC

Ticker: TRDA CUSIP: 29384C108 Class: Common Stock

GOLDMAN SACHS GROUP INC's Holding History (CIK: 0000886982)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 205,173 Value ($000) $2,109 Avg Close Range
Q3 2025
Shares 222,336 Value ($000) $1,290 Avg Close Range
Q2 2025
Shares 84,150 Value ($000) $565 Avg Close Range
Q1 2025
Shares 92,540 Value ($000) $837 Avg Close Range
Q4 2024
Shares 285,272 Value ($000) $4,932 Avg Close Range
Q3 2024
Shares 84,466 Value ($000) $1,350 Avg Close Range
Q2 2024
Shares 33,302 Value ($000) $475 Avg Close Range
Q1 2024
Shares 17,323 Value ($000) $245 Avg Close Range
Q4 2023
Shares 18,064 Value ($000) $273 Avg Close Range
Q3 2023
Shares 12,804 Value ($000) $202 Avg Close Range
Q2 2023
Shares 21,336 Value ($000) $323 Avg Close Range
Q1 2023
Shares 47,176 Value ($000) $684 Avg Close Range
Q4 2022
Shares 402,039 Value ($000) $5,436 Avg Close Range
Q3 2022
Shares 449,993 Value ($000) $7 Avg Close Range
Q2 2022
Shares 445,686 Value ($000) $5 Avg Close Range
Q1 2022
Shares 445,455 Value ($000) $4,183 Avg Close Range
Q4 2021
Shares 445,455 Value ($000) $7,626 Avg Close Range